Robert F. Kennedy Jr., nominated by President Trump to lead the U.S. Department of Health and Human Services (HHS), faced intense scrutiny during his confirmation hearing on January 29. Democratic senators questioned him about his past statements regarding COVID-19, particularly his controversial views on race and ethnicity in relation to the virus, as well as his outspoken opposition to vaccines.
One of the most heated moments of the hearing centered on Kennedy’s 2023 comments, made while running for president, where he suggested that COVID-19 could be “ethnically targeted,” disproportionately affecting certain races. In a statement caught on video, Kennedy claimed that “COVID-19 attacks certain races disproportionately,” with “Ashkenazi Jews and Chinese” being the least affected. The remarks were condemned as anti-Semitic, leading Kennedy to clarify on social media that he had never implied the virus was intentionally engineered to spare Jews. However, the comments were raised during the hearing, where Kennedy reiterated that he did not believe the virus was “deliberately targeted.”
Experts have strongly refuted Kennedy’s claims. Research from government health agencies has shown that the disproportionate impact of COVID-19 on Black and Hispanic communities was not due to biological factors but rather social determinants such as access to healthcare, underlying health conditions, and increased exposure due to essential jobs. “The idea of biological differences by race has been disproven,” said Samantha Artiga of the Kaiser Family Foundation.
Kennedy’s anti-vaccine stance was also a focal point during the hearing. Known for his longstanding criticism of vaccines, Kennedy has described COVID-19 lockdowns, mask mandates, and vaccine policies as excessive, even comparing them to the practices of Nazi Germany. His comments comparing vaccine mandates to the Holocaust led to widespread condemnation, prompting an apology from Kennedy. At the hearing, he also questioned the appropriateness of COVID-19 vaccines for young children, despite evidence from the Centers for Disease Control and Prevention (CDC) showing that vaccines are safe and effective for children.
Dr. Gregory Poland, president of Atria Research Institute, criticized Kennedy’s reliance on flawed evidence, noting that his claims often ignore scientific consensus. “Evidence-based medicine is completely based on the scientific method, which he evidently rejects,” Poland remarked.
As a potential head of HHS, Kennedy would have significant influence over public health policy, including vaccination guidelines. This has raised concerns about his ability to lead the U.S. response to future pandemics. “The guardrails are gone,” warned Dr. Eric Burnett, assistant professor at Columbia University. “Medical experts, people who are familiar with pandemics, just won’t be there.”
Kennedy, who has vowed to dedicate resources to preventing pandemics, was also questioned about his preparedness for future health crises, such as the growing threat of bird flu. However, some experts remain wary of his ability to handle such challenges, especially given the Trump Administration’s prior actions to weaken U.S. engagement with international health organizations, such as withdrawing from the World Health Organization.
The confirmation hearing highlighted a deep divide over Kennedy’s controversial views, leaving many uncertain about his suitability to lead the nation’s health response.
